Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Taiwan · Delayed Price · Currency is TWD

32.80

-0.20 (-0.61%)

Jun 18, 2026, 1:30 PM CST

-9.39% (1Y)

Market Cap	3.31B -11.5%
Revenue (ttm)	2.11B -6.2%
Net Income	204.95M -21.4%
EPS	2.02 -21.4%
Shares Out	100.99M
PE Ratio	16.24
Forward PE	n/a
Dividend	1.60 (4.88%)
Ex-Dividend Date	Jul 2, 2026

Volume	85,862
Open	33.00
Previous Close	33.00
Day's Range	32.80 - 33.15
52-Week Range	32.20 - 40.70
Beta	0.13
Analysts	Hold
Price Target	42.00 (+28.05%)
Earnings Date	Aug 7, 2026

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in a... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1963

Employees 552

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 1752

Full Company Profile

Financial Performance

In 2025, Nang Kuang Pharmaceutical's revenue was 2.16 billion, a decrease of -1.71% compared to the previous year's 2.20 billion. Earnings were 244.41 million, an increase of 0.41%.

Financial Statements